JPRN-UMIN000000798
Completed
Phase 4
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patients - FUJIYAMA Study 2
on profit Organization LINE0 sites60 target enrollmentAugust 15, 2007
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- on profit Organization LINE
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Endocrine hypertension 2\) Severe hypertension with office systolic blood pressure over 180mmHg and/or diastolic blood pressure over 90mmHg 3\) Malignant hypertension 4\) Continuous ventricular tachycardia or severe arrythmia (AV block II\-III, Af etc) 5\) Severe heart failure (NYHA III\-IV) 6\) Myocardial Infarction, Coronary bypass surgery, and Intervention therapy were performed within 6 months 7\) Patients with exclusion criteria of amlodipine, telmisartan and hedrochrolthiazide 8\) Serum creatinine \>2\.1mg/dl 9\) Serum potassium \>5\.5mEq/l or \<3\.5mEq/l 10\) Untreated hyperuricemia or treated hyperuricemia with UA\>8\.0mg/dl 11\) ACEI, ARB and Diuretic treated patients 12\) Uncontrolled diabetic patients (HbA1c\>9\.0%) and diabetic patients with insulin injection 13\) Hypoglycemia 14\) Hypersensitivity with telmisartan and hydrochrolthiazide 15\) Patients who are inadequate to entry this study by physicians in charge
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
effect of antihypertensive combination therapy with either CCB or diuretics on irbesartan on hypertensive patient with metabolic syndrome:A randomised controlled trialhypertensive patient with metabolic syndoromeJPRN-UMIN000003458Kanazawa Medical University Diabetes & Endocrinology40
Completed
Phase 4
Comparing anti-hypertensive combination therapy of fixed dose losartan and hydrochlorothiazide(HCTZ) versus angiotensin receptor blocker(ARB) and calcium channel blocker(CCB) on hypertensive patients whose blood pressures don't lower enough,effect and influence of metabolic system trial.HypertensionJPRN-UMIN000001692Hypertension and Metabolism Study group in East Saitama300
Completed
Phase 4
Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI> Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapyHypertensionJPRN-UMIN000001688Elderly Hypertension Conference200
Completed
Not Applicable
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemiaHypertension and dyslipidemiaJPRN-UMIN000008539Saitama Medical Center, Saitama Medical University30
Completed
Not Applicable
The effects of combined therapy for hypertension on arterial functiohypertension, type 2 diabetes mellitusJPRN-jRCT1091220034Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University60